Author

K. Adu-Berchie

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Stafford· 2 shared D. J. Mooney· 2 shared A. J. Najibi· 1 shared D. A. Barbie· 1 shared D. K. Y. Zhang· 1 shared E. A. Chiocca· 1 shared E. H. Knelson· 1 shared G. Berger· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Stafford

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enhancing adoptive T cell therapy with synergistic host immune engagement promotes long-term protection against solid tumors

K. Adu-Berchie, J. M. Brockman, Y. Liu, D. K. Y. Zhang, A. J. Najibi, A. Stafford, M. C. Sobral, Y. Binenbaum, M. O. Dellacherie, D. J. Mooney

This paper presents a biomaterial platform that enhances adoptive T cell therapy by engaging the host immune system, leading to better tumor control and long-term protection against solid tumors.

bioRxiv · Sep 10, 2022 · PreprintImmunology

STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models

G. Berger, E. H. Knelson, J. L. Jimenez-Macias, M. O. Nowicki, S. Han, P. H. Lizotte, K. Adu-Berchie, A. Stafford, N. Dimitrikakis, E. A. Chiocca, D. J. Mooney, D. A. Barbie, S. E. Lawler

This study shows that STING activation in glioblastoma models enhances immune responses and NK cell-mediated tumor regression, with long-term survival benefits in murine models.

bioRxiv · Feb 28, 2022 · PreprintCancer Biology